High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer (Q82770837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Pirus Ghadjar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Nicole Gwerder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Peter Manser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jacqueline Vock

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Axel Madlung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Roberto Mini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Daniel M Aebersold

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

30 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

Strahlentherapie und Onkologie

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

186

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

687-692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21136028%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00066-010-2180-8

17 January 2020

exact match

0 references

cites work

Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

1 reference

12 December 2020

Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer

1 reference

12 December 2020

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

12 December 2020

Urinary toxicity after high dose intensity modulated radiotherapy as primary therapy for prostate cancer.

1 reference

12 December 2020

Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate

1 reference

12 December 2020

Image-guided radiotherapy for prostate cancer. Implementation of ultrasound-based prostate localization for the analysis of inter- and intrafraction organ motion

1 reference

12 December 2020

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer

1 reference

12 December 2020

Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer

1 reference

12 December 2020

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

1 reference

12 December 2020

Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode.

1 reference

12 December 2020

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer

1 reference

12 December 2020

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

1 reference

12 December 2020

Acute and late toxicity in prostate cancer patients treated by dose escalated intensity modulated radiation therapy and organ tracking

1 reference

12 December 2020

IMRT of prostate cancer: a comparison of fluence optimization with sequential segmentation and direct step-and-shoot optimization.

1 reference

12 December 2020

Ultra-High Dose (86.4 Gy) IMRT for Localized Prostate Cancer: Toxicity and Biochemical Outcomes

1 reference

12 December 2020

Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectives.

1 reference

12 December 2020

Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial--Trans-Tasman Radiation Oncology Group

1 reference

12 December 2020

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

12 December 2020

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

1 reference

12 December 2020

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

12 December 2020

Nerve-sparing open radical retropubic prostatectomy

1 reference

12 December 2020

Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy

1 reference

12 December 2020

Dosimetric comparison of image guidance by megavoltage computed tomography versus bone alignment for prostate cancer radiotherapy

1 reference

12 December 2020

Moderate dose escalation in three-dimensional conformal localized prostate cancer radiotherapy: single-institutional experience in 398 patients comparing 66 Gy versus 70 Gy versus 74 Gy.

1 reference

12 December 2020

Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial.

1 reference

12 December 2020

Acute and late gastrointestinal toxicity after radiotherapy in prostate cancer patients: consequential late damage

1 reference

12 December 2020

Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer.

1 reference

12 December 2020